Retrospective analysis shows low complications and promising survival in pediatric patients with solid tumors, highlighting need for further prospective studies.
HIPEC demonstrated low rates of severe complications and promising survival outcomes. The main limitations include the retrospective design and tumor heterogeneity. Therefore, Large-scale prospective studies are warranted to validate these findings.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: